Nervovita Medical Technologies participated in IFESS 2026 alongside tVNS Health. The conference took place in Lecco, Italy, from 2 to 4 September 2026. Held at the Lecco Campus of Politecnico di Milano, the conference brought together researchers, physicians, physiotherapists, and engineers to explore recent developments in functional electrical stimulation, neuromodulation, neuroplasticity, and neurorehabilitation. Under the theme “From Lab to Life: Supporting Neuroplasticit

Nervovita Medical Technologies attended the 10th Congress on Swallowing Disorders, held at the İstinye University Vadi Campus Congress Centre from 3 to 7 December 2025. Bringing together approximately 500 participants and 58 speakers, the congress explored current scientific and clinical approaches to the assessment, management, and rehabilitation of adult and paediatric dysphagia. The scientific programme covered dysphagia management in Alzheimer’s disease and related dement

Nervovita Medical Technologies attended MEDICA 2025, held in Düsseldorf, Germany, from 17 to 20 November 2025. At MEDICA, one of the world’s leading medical technology trade fairs, we presented tVNS® non-invasive auricular vagus nerve stimulation technology to healthcare professionals, researchers, and industry representatives from around the world. At our stand in Hall 12, Stand F27, we shared information on tVNS® technology, its applications across clinical and research set

Nervovita Medical Technologies participated in Arab Health 2025 alongside tVNS Health, held at Dubai World Trade Centre from 27 to 30 January 2025. At Arab Health, one of the world’s leading healthcare and medical technology exhibitions, we presented tVNS® non-invasive auricular vagus nerve stimulation technology to an international audience of healthcare professionals, researchers, and industry representatives. At our stand in the Bavarian Pavilion, we shared insights into t

Nervovita Medical Technologies participated in the Polish Coma Symposium, which focused on tVNS applications in patients in coma and opportunities for future scientific research. Nervovita Medical Technologies participated in the Polish Coma Symposium, which focused on tVNS applications in patients in coma and opportunities for future scientific research. Transcutaneous vagus nerve stimulation in patients in coma has been an ongoing area of research, with contributions from s

Nervovita Medical Technologies team attended MEDICA 2024, held in Düsseldorf, Germany, from 11 to 14 November 2024. At MEDICA, one of the world’s leading medical technology trade fairs, we joined tVNS Health to introduce non-invasive auricular vagus nerve stimulation technology to healthcare professionals, researchers, and industry representatives. Throughout the event, we shared insights into the clinical and research applications of tVNS technology and explored potential co

Nervovita Medical Technologies joined tVNS Health in Dubai for Arab Health 2024, held from 29 January to 1 February 2024. At the tVNS Health stand at Dubai World Trade Centre, we presented tVNS® products and non-invasive auricular vagus nerve stimulation solutions to healthcare professionals and industry representatives from around the world. On the evening of 29 January, the opening day of the exhibition, we organised a clinical discussion meeting hosted by tVNS Health at Hi